Journal of PeriAnesthesia Nursing
Volume 25, Issue 3 , Pages 162-170 , June 2010

Care of the Adult Chronic Kidney Disease Patient in the Perianesthesia Setting

  • Holly Favero, MSN, CNN, ACNP-BC

      Affiliations

    • Corresponding Author InformationAddress correspondence to Holly Favero, Center for Vascular Access, St Mary Mercy Hospital, 36475 Five Mile Road, Livonia, MI 48154
    • ,
  • Margurite McMahon, RN

References 

  1. Collins AJ, Foley RN, Herzog C, et al. United States data system 2008 annual data report abstract. Am J Kidney Dis. 2009;53(Suppl 1):S1–S347
  2. McCullough PA, Jurkovitz CT, Pergola PE, et al. Independent components of chronic kidney disease as a cardiovascular risk state: Results from the kidney early evaluation program. Arch Intern Med. 2007;167:1122–1129
  3. National Kidney Foundation . KDOQI clinical practice recommendations for diabetes and chronic renal disease. Am J Kidney Dis. 2007;49(2 Suppl 3):S12–S154
  4. National Kidney Foundation . KDOQI clinical guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266
  5. Bellomo R, Ronco C, Kellum JA, et al. Acute Dialysis Quality Initiative Workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the acute dialysis quality initiative group. Crit Care. 2004;8:204–212
  6. Uchino S. Choice of therapy and renal recovery. Crit Care Med. 2004;36:S238–S242
  7. National Kidney Foundation . KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: Hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis. 2006;48(Suppl 1):S1–S322
  8. In:  Davidson I editors. Access for Dialysis: Surgical and Radiologic Procedures. 2nd ed. Georgetown, TX: Landes Bioscience; 2002;
  9. Vascular Access 2006 Workgroup . Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl 1):S176–S247
  10. Taylor G, Gravel D, Johnston L, et al. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol. 2002;23:716–720
  11. Dopirak M, Hill C, Oleksiw M, et al. Surveillance of hemodialysis-associated primary bloodstream infections: The experience of ten hospital-based centers. Infect Control Hosp Epidemiol. 2002;23:721–724
  12. Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–555
  13. El Minshawy O, Abd El Aziz T, Abd El Ghani H. Evaluation of vascular access complications in acute and chronic hemodialysis. J Vasc Access. 2004;5:76–82
  14. Mazonakis E, Stirling C, Booth KL, et al. The influence of comorbidity on the risk of access-related bacteremia in chronic hemodialysis patients. Hemodialysis Int. 2009;13:6–10
  15. Wali RK, Henrich WL. Chronic kidney disease: A risk factor for cardiovascular disease. Cardiol Clin. 2005;23:343–362
  16. Krishnan M. Preoperative care of patients with kidney disease. Am Fam Physician. 2002;66:1471–1476
  17. National Kidney Foundation . KDOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 Suppl 1):S1–S290
  18. Venkat A, Kaufmann KR, Venkat KK. Care of the end-stage renal disease patient on dialysis in the ED. Am J Emerg Med. 2006;24:847–858
  19. Shen YP, Frenkle EP. Acquired platelet dysfunction. Hematol Oncol Clin North Am. 2007;21:647–661
  20. Kazmi WH, Kausz AT, Khan S, et al. Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38:803–812
  21. Levin A. Cardiac disease in chronic kidney disease: Current understanding and opportunities for change. Blood Purif. 2004;22:21–22
  22. Silverberg D, Wexler D, Blum M, et al. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens. 2004;13:163–170
  23. Silverberg D, Wexler D. Anemia, the fifth major cardiovascular risk factor. Transfus Med Hemother. 2004;31:175–179
  24. National Kidney Foundation . KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic renal disease: 2007 update of hemoglobin target. Am J Kidney Dis. 2007;50:471–530
  25. Hébert PC, VanDerLinden P, Biro G, et al. Physiologic aspects of anemia. Crit Care Clin. 2004;20:187–212
  26. Munar MY, Singh H. Drug dosing adjustments in patients with chronic kidney disease. Am Fam Physician. 2007;75:1487–1496
  27. Li JM. Pain management in the hospitalized patient. Med Clin North Am. 2008;92:371–385
  28. Evans K, Greenberg A. Hyperkalemia: A review. Intensive Care Med. 2005;20:272–290
  29. Schaefer T, Wolford R. Disorders of potassium. Emerg Med Clin North Am. 1999;23:723–747
  30. Aslam S, Friedman AE, Ifudi O. Electrocardiography is unreliable in detecting potentially lethal hyperkalaemia in haemodialysis patients. Nephrol Dial Transplant. 2002;17:1639–1642
  31. Evans K, Reddan D, Szczech L. Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: An evaluation of the evidence. Semin Dial. 2004;17:22–29
  32. Hoggard J, Saad T, Schon D, et al. Guidelines for venous access in patients with chronic kidney disease. Semin Dial. 2008;21:186–191
  33. Bower DJ, LaMenodila B. Optimizing hemodialysis cannulation methods. Endovascular Today. 2009;58–64
  34. Sidawy AN, Spergel LM, Besarab A, et al. The society for vascular surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg. 2008;48:S2–S25
  35. Dugan L, Leech L, Speroni KG, et al. Factors affecting hemolysis rates in blood samples drawn from newly placed IV sites in the emergency department. J Emerg Nurs. 2005;31:338–345
  36. Lippi G. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med. 2006;44:311–316
  37. Bush V, Mangan L. The hemolyzed specimen: Causes, effects, and reduction. Lab Notes. 2003;13:1–5
  38. Hollander-Rodriguez JC, Calvert JF. Hyperkalemia. Am Fam Physician. 2006;73:283–290
  39. Von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;44:1–16
  40. Hinds P, Quargnenti A, Gattuso J, et al. Comparing the results of coagulation tests on blood drawn by venipucture and through heparinized tunneled venous access devices in pediatric patients with cancer. Oncol Nurs Forum. 2002;29:E26–E34
  41. Karkouti K, McCluskey SA, Ghannam M, et al. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Can J Anaesth. 2006;53:11–19
  42. Salman L, Maya ID, Asif A. Current concepts in the pathophysiology and management of arteriovenous access-induced hand ischemia. Adv Chronic Kidney Dis. 2009;16:371–337
  43. Breiterman-White R. Infection and inflammation in patients on dialysis: An underlying contributor to anemia and epoetin alfa hyporesponse. Nephrol Nurs J. 2006;33:319–332
  44. Saran R, Bragg-Gresham JL, Rayner H, et al. Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the dopps. Kidney Int. 2003;64:254–262
  45. White RB. Adherence to the dialysis prescription: Partnering with patients for improved outcomes. Nephr Nurs J. 2004;31:432–435

PII: S1089-9472(10)00119-X

doi: 10.1016/j.jopan.2010.03.009

Journal of PeriAnesthesia Nursing
Volume 25, Issue 3 , Pages 162-170 , June 2010

Article Tools

* Image Usage & Resolution